ArticleBMJ open2022

Efficacy of the Gelstix nucleus augmentation device for the treatment of chronic discogenic low back pain: protocol for a randomised, sham-controlled, double-blind, multicentre trial.

Eva Koetsier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.